93 related articles for article (PubMed ID: 10570926)
1. NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1.
Matsuo M; Tucker SJ; Ashcroft FM; Amachi T; Ueda K
FEBS Lett; 1999 Sep; 458(3):292-4. PubMed ID: 10570926
[TBL] [Abstract][Full Text] [Related]
2. MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
Ueda K; Inagaki N; Seino S
J Biol Chem; 1997 Sep; 272(37):22983-6. PubMed ID: 9287292
[TBL] [Abstract][Full Text] [Related]
3. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
Ueda K; Komine J; Matsuo M; Seino S; Amachi T
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
[TBL] [Abstract][Full Text] [Related]
4. Direct photoaffinity labeling of Kir6.2 by [gamma-(32)P]ATP-[gamma]4-azidoanilide.
Tanabe K; Tucker SJ; Ashcroft FM; Proks P; Kioka N; Amachi T; Ueda K
Biochem Biophys Res Commun; 2000 Jun; 272(2):316-9. PubMed ID: 10833411
[TBL] [Abstract][Full Text] [Related]
5. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy.
Matsuo M; Trapp S; Tanizawa Y; Kioka N; Amachi T; Oka Y; Ashcroft FM; Ueda K
J Biol Chem; 2000 Dec; 275(52):41184-91. PubMed ID: 10993895
[TBL] [Abstract][Full Text] [Related]
7. Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins.
Ueda K; Matsuo M; Tanabe K; Morita K; Kioka N; Amachi T
Biochim Biophys Acta; 1999 Dec; 1461(2):305-13. PubMed ID: 10581363
[TBL] [Abstract][Full Text] [Related]
8. Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.
Masia R; Caputa G; Nichols CG
Channels (Austin); 2007; 1(4):315-23. PubMed ID: 18708750
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
[TBL] [Abstract][Full Text] [Related]
11. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
12. ATP binding properties of the nucleotide-binding folds of SUR1.
Matsuo M; Kioka N; Amachi T; Ueda K
J Biol Chem; 1999 Dec; 274(52):37479-82. PubMed ID: 10601323
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of Japanese patients with persistent hyperinsulinemic hypoglycemia of infancy: nucleotide-binding fold-2 mutation impairs cooperative binding of adenine nucleotides to sulfonylurea receptor 1.
Tanizawa Y; Matsuda K; Matsuo M; Ohta Y; Ochi N; Adachi M; Koga M; Mizuno S; Kajita M; Tanaka Y; Tachibana K; Inoue H; Furukawa S; Amachi T; Ueda K; Oka Y
Diabetes; 2000 Jan; 49(1):114-20. PubMed ID: 10615958
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
Hambrock A; Löffler-Walz C; Quast U
Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
[TBL] [Abstract][Full Text] [Related]
15. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
[TBL] [Abstract][Full Text] [Related]
16. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
17. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
Cartier EA; Conti LR; Vandenberg CA; Shyng SL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
[TBL] [Abstract][Full Text] [Related]
18. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
19. A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.
Wada Y; Yamashita T; Imai K; Miura R; Takao K; Nishi M; Takeshima H; Asano T; Morishita R; Nishizawa K; Kokubun S; Nukada T
EMBO J; 2000 Sep; 19(18):4915-25. PubMed ID: 10990455
[TBL] [Abstract][Full Text] [Related]
20. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
